Please assess the completion status of the following clinical trial:

Trial Title: Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Smoking adults aged ≥ 18 years intending to quit tobacco use who are prescribed Varenicline (Champix™) by their Physicians and those who are prescribed with Varenicline (Champix™) for the first time.~Exclusion Criteria:~* Subjects in whom varenicline (Champix™) may be taken in a manner that is not according to the approved local product document.~* Pregnant or lactating women, or women of childbearing potential not using an acceptable method of contraception~* Subjects with known hypersensitivity to varenicline.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open-label (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).